Why Surgery Partners Inc’s (SGRY) Stock Is Down 5.43%

By AAII Staff
June 20, 2024
Featured Tickers:

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Surgery Partners Inc before investing.

In this article, we go over a few key elements for understanding Surgery Partners Inc’s stock price such as:

  • Surgery Partners Inc’s current stock price and volume
  • Why Surgery Partners Inc’s stock price changed recently
  • Upgrades and downgrades for SGRY from analysts
  • SGRY’s stock price momentum as measured by its relative strength

About Surgery Partners Inc (SGRY)

Before we jump into Surgery Partners Inc’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Surgery Partners, Inc. is a healthcare services company. The Company, through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services. Its segments include Surgical Facility Services and Ancillary Services. The Surgical Facility Services segment consists of the operation of ASCs and surgical hospitals and includes its anesthesia services. Its surgical facilities primarily provide non-emergency surgical procedures across many specialties, including, among others, orthopedics and pain management, ophthalmology, gastroenterology and general surgery. The Ancillary Services segment consisted of multi-specialty physician practices, including physician practices owned and operated pursuant to long-term management service agreements. It is focused on surgical services businesses in the United States, with over 180 locations in 33 states, including ambulatory surgery centers, short-stay surgical hospitals, and multi-specialty physician practices.

Want to learn more about Surgery Partners Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Surgery Partners Inc.

Learn More About A+ Investor

Surgery Partners Inc’s Stock Price as of Market Close

As of June 20, 2024, 4:00 PM, CST, Surgery Partners Inc’s stock price was $23.69.

Surgery Partners Inc is down 5.43% from its previous closing price of $25.05.

During the last market session, Surgery Partners Inc’s stock traded between $24.82 and $25.49. Currently, there are 125.97 million shares of Surgery Partners Inc stock available for purchase.

Unfortunately, Surgery Partners Inc’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.

Surgery Partners Inc Stock Price History

Surgery Partners Inc’s (SGRY) price is currently down 14.17% so far this month.

During the month of June, Surgery Partners Inc’s stock price has reached a high of $27.94 and a low of $23.47.

Over the last year, Surgery Partners Inc has hit prices as high as $45.79 and as low as $22.05. Year to date, Surgery Partners Inc’s stock is down 14.97%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Surgery Partners Inc Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of June 18, 2024, there were 0 analysts who downgraded Surgery Partners Inc’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Surgery Partners Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Surgery Partners Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Surgery Partners Inc’s current valuation based on AAII’s Value Grade is a C, which means it is considered to be Average.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Surgery Partners Inc (SGRY) by visiting AAII Stock Evaluator.

Relative Price Strength of Surgery Partners Inc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of June 18, 2024, Surgery Partners Inc has a weighted four-quarter relative price strength of -15.76%, which translates to a Momentum Score of 25 and is considered to be Weak.

Want to learn more about how Surgery Partners Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Surgery Partners Inc Stock Price: Bottom Line

As of June 20, 2024, Surgery Partners Inc’s stock price is $23.69, which is down 5.43% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Surgery Partners Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Learn More About A+ Investor

Find New Stock Opportunities With Included With AAII Platinum
O'Shaughnessy Tiny Titans
Screen:
23.7%
Annual Gain Since Inception. Data as of 12/31/2024.




Try AAII Platinum and get full access to
769.3% Stock Superstars Portfolio Total Return Since Inception
Compare to:
710.3% iShare DOW Jones
U.S. Index ETF (IYY)

SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.

Get your free copy of our special report analyzing the tech stocks most likely to outperform the market.

Download the FREE Report Here:

BECOME A MEMBER FOR ONLY $2

Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.